Share on Facebook Share on Twitter Email
Answers.com

dementia

Did you mean: dementia (in psychology), Dementia (film), Dementia (1999 Thriller Film)

 

Definition

Dementia is a loss of mental ability severe enough to interfere with normal activities of daily living, lasting more than six months, not present since birth, and not associated with a loss or alteration of consciousness.

Description

Dementia is a group of symptoms caused by gradual death of brain cells. The loss of cognitive abilities that occurs with dementia leads to impairments in memory, reasoning, planning, and personality. While the over-whelming number of people with dementia are elderly, it is not an inevitable part of aging. Instead, dementia is caused by specific brain diseases. Alzheimer's disease (AD) is the most common cause, followed by vascular or multi-infarct dementia.

The prevalence of dementia has been difficult to determine, partly because of differences in definition among different studies, and partly because there is some normal decline in functional ability with age. Dementia affects 5–8% of all people between ages 65 and 74, and up to 20% of those between 75 and 84. Estimates for dementia in those 85 and over range from 30–47%. Between two and four million Americans have AD; that number is expected to grow to as many as 14 million by the middle of the twenty-first century as the population as a whole ages.

The cost of dementia can be considerable. While most people with dementia are retired and do not suffer income losses from their disease, the cost of care is often enormous. Financial burdens include lost wages for family caregivers, medical supplies and drugs, and home modifications to ensure safety. Nursing home care may cost several thousand dollars a month or more. The psychological cost is not as easily quantifiable but can be even more profound. The person with dementia loses control of many of the essential features of his life and personality, and loved ones lose a family member even as they continue to cope with the burdens of increasing dependence and unpredictability.

— Richard Robinson



Search unanswered questions...
Enter a question here...
Search: All sources Community Q&A Reference topics
Dictionary: de·men·tia   (dĭ-mĕn'shə) pronunciation
Top
n.
  1. Deterioration of intellectual faculties, such as memory, concentration, and judgment, resulting from an organic disease or a disorder of the brain. It is sometimes accompanied by emotional disturbance and personality changes.
  2. Madness; insanity. See synonyms at insanity.

[Latin dēmentia, madness, from dēmēns, dēment-, senseless. See dement.]

demential de·men'tial adj.


Chronic, usually progressive deterioration of intellectual functions. Most common in the elderly, it usually begins with short-term-memory loss once thought a normal result of aging but now known to result from Alzheimer disease. Other common causes are Pick disease and vascular disease. Dementia also occurs in Huntington chorea, paresis (see paralysis), and some types of encephalitis. Treatable causes include hypothyroidism (see thyroid gland), other metabolic diseases, and some malignant tumours. Treatment may arrest dementia's progress but usually does not reverse it.

For more information on dementia, visit Britannica.com.

Neurological Disorder:

Dementia

Top

Definition

The term dementia refers to symptoms, including changes in memory, personality, and behavior, that result from a change in the functioning of the brain. These declining changes are severe enough to impair the ability of a person to perform a function or to interact socially. This operating definition encompasses 70–80 different types of dementia. They include changes due to diseases (Alzheimer's and Creutzfeld-Jakob diseases), changes due to a heart attack or repeated blows to the head (as suffered by boxers), and damage due to long-term alcohol abuse.

Dementia is not the same thing as delirium or mental retardation. Delirium is typically a brief state of mental confusion often associated with hallucinations. Mental retardation is a condition that usually dates from childhood and is characterized by impaired intellectual ability; mentally retarded individuals typically have IQ (intelligence quotient) scores below 70 or 75.

Description

The absent-mindedness and confusion about familiar settings and tasks that are hallmarks of dementia used to be considered as part of a typical aging pattern in the elderly. Indeed, dementia historically has been called senility. Dementia is now recognized not to be a normal part of aging. The symptoms of dementia can result from different causes. Some of the changes to the brain that cause dementia are treatable and can be reversed, while other changes are irreversible.

Demographics

An estimated two million people in the United States alone have severe dementia. Up to five million more people in the United States have milder forms of cognitive impairment of the dementia type. The elderly are most prone to dementia, particularly those at risk for a stroke. The historical tendency of women to live longer than men has produced a higher prevalence of dementia in older women. However, women and men are equally prone to dementia. Over age 80, more than 20% of people have at least a mild form of dementia.

Causes and symptoms

Dementia is especially prominent in older people. The three main irreversible causes are Alzheimer's disease, dementia with Lewy bodies, and multi-infarct dementia (also called vascular dementia).

Degenerative forms of dementia are long lasting (chronic) and typically involve a progressive loss of brain cell function. In disorders like Alzheimer's and Creutzfeld-Jakob diseases, this can involve the presence of infectious agents that disturb the structure of proteins that are vital for cell function. Other forms of dementia are chemically based. For example, Parkinson's disease involves the progressive loss of the ability to produce the neurotransmitter dopamine. Interrupted transmission of nerve impulses causes the progressive physical and mental deterioration. Huntington's disease is an inherited form of dementia that occurs when neurons (brain cells) degenerate.

Alzheimer's disease is the most common cause of dementia. The progressive death of nerve cells in the brain is associated with the formation of clumps (amyloid plaques) and tangles of protein (neurofibrillary tangles) in the brain. The loss of brain cells with time is reflected in the symptoms; minor problems with memory become worse, and impairment in normal function can develop. Alzheimer's patients also have a lower level of a chemical that relays nerve impulses between nerve cells. As the brain damage progresses, other complications can ensue from the damage and these can prove fatal. Put another way, people die with Alzheimer's, not from it.

Dementia resulting from the abnormal formation of protein in the brain (Lewy bodies) is the second most common form of dementia in the elderly. It is unclear whether these structures are related to the brain abnormalities noted in Alzheimer's patients. Lewy body formation differs from Alzheimer's in that the speed of brain functions is affected more so than memory.

In multi-infarct dementia, blood clots can dislodge and impede the flow of blood in blood vessels in the brain. The restricted flow of blood can lead to death of brain cells and a stroke.

Dementias that are caused by the blockage of blood vessels are generally known as vascular dementia. This type of dementia can sometimes be reversed if the blood-vessel blockage can be alleviated. In contrast, the dementia associated with Alzheimer's disease is non-reversible.

Less common causes of dementia include Binwanger's disease (another vascular type of dementia), Parkinson's disease, Pick's disease, Huntington's disease, Creutzfeldt-Jakob disease, and acquired immunodeficiency syndrome (AIDS).

A study published in 2002 documented a link between elevated levels of an amino acid called homocysteine in the blood and the risk of developing dementia, likely vascular dementia. As homocysteine concentration can be modified by diet, the finding holds the potential that one risk factor for dementia may be controllable.

Symptoms of dementia include repeatedly asking the same question; loss of familiarity with surroundings; increasing difficulty in following directions; difficulty in keeping track of time, people, and locations; loss of memory; changes in personality or emotion; and neglect of personal care. Not everyone displays all symptoms. Indeed, symptoms vary based on the cause of the dementia. Also, symptoms can progress at different rates in different people.

Diagnosis

Diagnosis of dementia typically involves a medical examination, testing of mental responses (such as memory, problem solving, and counting), and knowledge of the patient's medical history (e.g., prescription and non-prescription drug use, nutrition, results of a physical examination, and medical history). Testing of the composition of the blood and urine can be helpful in ruling out specific causes such as thyroid disease or a deficiency in vitamin B12. Some blood tests can help alert clinicians to the possibility of dementia. For example, persons infected with the human immunodeficiency virus (HIV) have distinct proteins in their blood that are often associated with the presence of dementia.

Visual examination of the brain can reveal structural abnormalities associated with dementia. Tests that are typically performed are computerized tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET). While accurate, such tests are not commonplace, and are rarely encountered outside of the research setting. Neuroimaging (CT or MRI scans) can be useful in excluding the possibility that dementia has resulted from an occlusion of a blood vessel, as in a stroke or due to the presence of a tumor.

Treatment team

Family physicians, medical specialists such as neurologists and psychiatrists, physical therapists, counselors, personal caregivers, and family members can all be part of the treatment team for someone afflicted with dementia.

Treatment

Drugs can help delay the progression of symptoms, particularly for Alzheimer's disease. The high blood pressure that is associated with multi-infarct dementia can also be controlled by drug therapy. Other stroke risk factors that can be treated include cholesterol level, diabetes, and smoking. Medicines such as antidepressants, antipsychotics, and anxiolytics can also be used to treat behaviors associated with dementia, including insomnia, anxiety, depression, and nervousness.

Other treatments that do not involve drugs are the maintenance of a healthy diet, regular exercise, stimulating activities and social contacts, and making the home as safe as possible. Hobbies can help keep the mind occupied and stimulated. "Things-to-do" lists can be a helpful memory prompt for persons with early dementia. With more advanced disease, a facility specializing in Alzheimer's treatment often provides a stimulating modified environment along with meeting increasing medical and personal care needs.

Recovery and rehabilitation

Irreversible causes of dementia reduce or eliminate the chances of recovery and rehabilitation. Stimuli such as favorite family photographs and calendars provide clues to cognitive orientation, while devices such as walkers help maintain mobility for as long as possible.

Clinical trials

As of early 2004, there are 64 clinical trials for dementia study and treatment in the United States that are recruiting subjects. The trials range from improved strategies of care and telephone support to active interventions in the outcome of various forms of dementia. The bulk of the trials are concerned with Alzheimer's disease. Information about the trials can be found at the National Institutes of Health (NIH) sponsored clinical trials website.

Prognosis

For those with irreversible progressive dementia, the outlook often includes slow deterioration in mental and physical capacities. Eventually, help is often required when swallowing, walking, and even sitting become difficult. Aid can consist of preparing special diets that can be more easily consumed and making surroundings safe in case of falls. Lift assists in areas such as the bathroom can also be useful.

For those with dementia, the expected lifespan is often reduced from that of a healthy person. For example, in Alzheimer's disease, deterioration of areas of the brain that are vital for body functions can threaten survival.

Special concerns

Caring for an individual with dementia almost always challenges family resources. Licensed social service providers at hospitals and facilities for the elderly can provide information and referrals regarding support groups, mental health agencies, community resources, and personal care providers to assist families in caring for a person with dementia.

Resources

BOOKS

Bird, T. D. "Memory Loss and Dementia." In Harrison's Principles of Internal Medicine, 15th edition. Edited by A. S. Franci, E. Daunwald, and K. J. Isrelbacher. New York: McGraw Hill, 2001.

Castleman, Michael, et al. There's Still a Person in There: The Complete Guide to Treating and Coping With Alzheimer's. New York: Perigee Books, 2000.

Mace, Nancy L., and Peter V. Rabins. The 36-Hour Day: A Family Guide to Caring for Persons with Alzheimer Disease, Related Dementing Illnesses, and Memory Loss in Later Life. New York: Warner Books, 2001.

PERIODICALS

Sullivan, S. C., and K. C. Richards. "Special Section—Behavioral Symptoms of Dementia: Their Measurement and Intervention." Aging and Mental Health (February 2004): 143–152.

Seshadri, S., et al. "Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease." New England Journal of Medicine (February 2002): 476–483.

OTHER

Mayo Clinic. Dementia: It's Not Always Alzheimer's. December 23, 2003 (March 30, 2004). http://www.mayoclinic.com/invoke.cfm?id=AZ00003.

National Institute on Aging. Forgetfulness: It's Not Always What You Think. December 23, 2003 (March 30, 2004). http://www.niapublications.org/engagepages/forgetfulness.asp.

ORGANIZATIONS

Alzheimer's Association. 919 Michigan Avenue, Suite 1100, Chicago, IL 60611-1676. (312) 335-8700 or (800) 272-3900; Fax: (312) 335-1110. info@alz.org. http://www.alz.org.

Alzheimer's Disease Education and Referral Center. P. O. Box 8250, Silver Spring, MD 20907-8250. (301) 495-3334 or (800) 438-4380. adear@alzheimers.org. http://www.alzheimers.org.

National Institute on Aging. 31 Center Drive, MSC 2292, Building 31, Room 5C27, Bethesda, MD 20892. (301) 496-1752 or (800) 222-2225. karpf@nia.nih.gov. http://www.nia.nih.gov.

National Institute for Neurological Disorders and Stroke. P. O. Box 5801, Bethesda, MD 20824. (301) 496-5761 or (800) 352-9424. http://www.ninds.nih.gov.

National Institute of Mental Health. 6001 Executive Boulevard, Room 8184, MSC 9663, Bethesda, MD 20892-9663. (301) 443-4513 or (866) 615-6464; Fax: (301) 443-4279. nimhinfo@nih.gov. http://www.nimh.nih.gov.


Brian Douglas Hoyle, PhD


World of the Body: dementia
Top

…Last scene of all,
That ends this strange eventful history,
Is second childishness, and mere oblivion,
Sans teeth, sans eyes, sans taste, sans everything
[Shakespeare, As You Like It]

We all fear disintegration of the mind, and rightly so; it robs us of our dignity. Bereft of reason we cannot contribute to society, vote, write a will, nor with time care for our basic needs. The disintegration of the mind, or dementia, is a familiar occurrence in the elderly but can occur at any age and result from a vast array of diseases. The loss of acquired intellectual skills — the characteristic feature of dementia — is distinct from developmental failure, which results in learning difficulties of variable severity. We may also be robbed of our senses by sleep or inebriation, and so the term ‘dementia’ is restricted to individuals who are awake and alert. Similarly, patients with a restricted cognitive deficit such as impairment of language following a stroke may have a very different prognosis, with preservation of other intellectual functions, when compared with the widespread disintegration commonly seen with the dementing diseases. A definition of dementia has thus emerged to describe an individual who is alert but who suffers impairment in more than one cognitive domain, of sufficient severity to impair social function. A difficulty in applying the definition is to decide what is a specific cognitive domain. Impairment of memory is considered essential, or more specifically impairment of event memory: that which allows us to recall day-to-day events and maintains our sense of continuity; impairment of memory is a salient feature of Alzheimer's disease, the commonest cause of dementia. Other cognitive domains may include language; visuospatial and visuoperceptual functions, which allow interpretation of our visual world; and so-called ‘frontal executive skills’, which allow us to plan and select appropriate responses to our environment.

It is important to emphasize that dementia is a syndrome and not a disease. The challenge to the clinician is to identify the underlying cause, of which there are many. Alzheimer's disease is the commonest, particularly in the elderly; it is thus the main cause of ‘senile dementia’, a term that is becoming obsolete. It was described in 1906 by Alois Alzheimer, and was considered a rarity occurring in relatively young people (‘pre-senile dementia’), until the 1960s, when it was recognized that the microscopic abnormalities described by Alzheimer were also found in the demented elderly. This led to an apparent epidemic as patients were reassigned from the categories of ‘just old age’ or ‘senile dementia’ to Alzheimer's disease.

Alzheimer had exploited the newly-discovered silver staining method for microscopic examination of nerve tissue, to visualize abnormal cellular changes in the brain. He studied the brain of a 51-year-old patient, Auguste D., whom he had seen whilst working in Frankfurt and who died at the age of 54 years with severe dementia. He reported the hallmark features: ‘neurofibrillary tangles’ and ‘senile plaques’. Recent research has shown that the neurofibrillary tangle results from a collapse of the ‘internal skeleton’ of brain cells (the neuronal cytoskeleton). Senile plaques consist of disrupted neuronal connections, axons, and dendrites, around a core of abnormal deposits of a protein called beta amyloid. This protein undergoes a change in shape that renders it harmful to the cell; exactly how and why these changes occur is the subject of intense research aimed at finding effective treatments.

Alzheimer's disease is the prototypic dementia, characteristically starting with mild forgetfulness and a tendency to repetition in conversation: memory failure worsens, with appointments and recent events forgotten. Losing their way, at first in unfamiliar and then in familiar surroundings, patients become increasingly bemused and testy. Failure of language follows, with increasing difficulty in making sense of the world around them. Dressing, feeding, and toiletting all require help before the final stage ‘sans everything’.

A variety of other degenerative diseases have been, and are being, identified as causes of dementia, including Creutzfeldt Jakob disease and Pick's disease. The latter was described as long ago as 1894. Arnold Pick, a neurologist from Prague, reported a patient with loss of language who was found to have circumscribed shrinkage or atrophy of the temporal lobe, the area of the brain involved with language function. Pick reported the case to disprove the prevailing dogma that all senile atrophies inevitably involved the whole brain. It was Alzheimer's subsequent analysis of such cases that identified silver-stained ‘Pick bodies’ as distinct from the neurofibrillary tangles of his own eponymous disease. Pick's disease is rare and cannot be reliably diagnosed without examination of brain tissue after death, and so is generally swept up in the wider diagnostic category of the fronto-temporal degenerations. Reflecting the areas of the brain affected, such patients present with impairment of language or of social behaviour; whilst at first the symptoms may be confined to one cognitive domain, other functions decline and the clinical picture becomes that of a dementia.

Before the demonstration that the changes of Alzheimer's disease were the common accompaniment of dementia in old age, it used to be thought that such cases were due to a failure of the blood supply, starving the brain of oxygen. There is no evidence that this is so, but multiple strokes can result in dementia, as can multiple haemorrhages into the brain. These are subsumed within the broad category of vascular dementia, which represents the second commonest cause of cognitive impairment, according to some reports.

The ‘use it or lose it’ school of thought argues that education may in part protect us from Alzheimer's disease. But no one is exempt. Scholars, scientists, artists, and statesmen have all succumbed. The publicity surrounding Ronald Reagan's diagnosis of Alzheimer's disease has done much to focus research funding, whereas the same diagnosis in Finland's President may have affected his ability to govern in the last few years of office in the early 1980s.

A small minority of dementias are eminently treatable, and vascular dementia is anticipated to become less common with better management of risk factors such as heart disease, hypertension, and smoking. The major challenge is Alzheimer's disease, and the challenge is a global one, with a predicted 34 million affected individuals by the year 2025. Most will be in the emerging nations, where life expectancy is increasing. In China this is combined with a policy of one child per family, such that the future work force will have to provide for a disproportionate dependent population; the solution will owe as much to politics as to medicine.

The conceptual shift in our understanding of dementia has been profound; no longer is it seen as an inevitable concomitant of old age. Instead we can view Alzheimer's disease, the major cause of late life dementia, as a disease with distinct physical changes, which should be amenable to treatment. However, we should not confuse this with the inevitable changes of ageing. We cannot run as fast at 90 as at 20, nor can we think as fast. We can, though, anticipate the preservation of wisdom and knowledge; to exploit the latter is a challenge for society, to preserve them and avoid dementia is a challenge for medicine.

— Martin Rossor

See also ageing; memory; psychological disorders; senility.

Thesaurus: dementia
Top

noun

    Serious mental illness or disorder impairing a person's capacity to function normally and safely: brainsickness, craziness, derangement, disturbance, insaneness, insanity, lunacy, madness, mental illness, psychopathy, unbalance. Psychiatry mania. Psychology aberration, alienation. See sane/insane.

Antonyms: dementia
Top

n

Definition: mental illness
Antonyms: sanity


Dental Dictionary: dementia
Top

n

A progressive, organic mental disorder characterized by chronic personality disintegration, confusion, disorientation, stupor, deterioration of intellectual capacity and function, and impairment or control of memory, judgment, and impulses (for example, senile psychosis, also associated with AIDS).

Definition

Dementia is a loss of mental ability severe enough to interfere with normal activities of daily living, lasting more than six months, not present since birth, and not associated with a loss or alteration of consciousness.

Description

Dementia is a group of symptoms caused by gradual death of brain cells. The loss of cognitive abilities that occurs with dementia leads to impairments in memory, reasoning, planning, and personality. While the over-whelming number of people with dementia are elderly, it is not an inevitable part of aging. Instead, dementia is caused by specific brain diseases. Alzheimer's disease is the most common cause, followed by vascular or multi-infarct dementia.

The prevalence of dementia has been difficult to determine, partly because of differences in definition among different studies, and partly because there is some normal decline in functional ability with age. Dementia affects 5–8% of all people between ages 65 and 74, and up to 20% of those between 75 and 84. Estimates for dementia in those 85 and over range from 30–47%. Between two and four million Americans have Alzheimer's disease; that number is expected to grow to as many as 14 million by the middle of the twenty-first century as the population as a whole ages.

The cost of dementia can be considerable. While most people with dementia are retired and do not suffer income losses from their disease, the cost of care is often enormous. Financial burdens include lost wages for family caregivers, medical supplies and drugs, and home modifications to ensure safety. Nursing home care may cost several thousand dollars a month or more. The psychological cost is not as easily quantifiable but can be even more profound. The person with dementia loses control of many of the essential features of his life and personality, and loved ones lose a family member even as they continue to cope with the burdens of increasing dependence and unpredictability.

Causes & Symptoms

Causes

Dementia is usually caused by degeneration of brain cells in the cerebral cortex, the part of the brain responsible for thoughts, memories, actions, and personality. Death of brain cells in this region leads to the cognitive impairment that characterizes dementia.

The most common cause of dementia is Alzheimer's disease (AD), accounting for half to three quarters of all cases. The brain of a person with AD becomes clogged with two abnormal structures, called neurofibrillary tangles and senile plaques. Neurofibrillary tangles are twisted masses of protein fibers inside nerve cells, or neurons. Senile plaques are composed of parts of neurons surrounding a group of proteins called beta-amyloid deposits. Why these structures develop is unknown. Current research indicates possible roles for inflammation, blood flow restriction, and accumulation of aluminum in the brain and toxic molecular fragments known as free radicals or oxidants.

Several genes have been associated with higher incidences of AD, although the exact role of these genes is still unknown. In 2001, investigators discovered a rare mutation in the amyloid precursor protein (APP) that is linked to early-onset Alzheimer's. The discovery points scientists to new ideas for targeting and treating the disease.

Vascular dementia is estimated to cause from 5–30% of all dementias. It occurs from a decrease in blood flow to the brain, most commonly due to a series of small strokes (multi-infarct dementia). Other cerebrovascular causes include: vasculitis from syphilis, Lyme disease, or systemic lupus erythematosus; subdural hematoma; and subarachnoid hemorrhage. Because of the usually sudden nature of its cause, the symptoms of vascular dementia tend to begin more abruptly than those of Alzheimer's dementia. Symptoms may progress stepwise with the occurrence of new strokes. Unlike AD, the incidence of vascular dementia is lower after age 75.

Other conditions which may cause dementia include:

Symptoms

Dementia is marked by a gradual impoverishment of thought and other mental activities. Losses eventually affect virtually every aspect of mental functioning. The slow progression of dementia is in contrast with delirium, which involves some of the same symptoms, but has a very rapid onset and fluctuating course with alteration in the level of consciousness. However, delirium may occur with dementia, especially since the person with dementia is more susceptible to the delirium-inducing effects of may types of drugs.

Symptoms include:

  • Memory losses. Short-term memory loss is usually the first symptom noticed. It may begin with misplacing valuables such as a wallet or car keys, then progress to forgetting appointments, where the car was left, and the route home, for instance. More profound losses may eventually follow, such as forgetting the names and faces of family members.
  • Impaired abstraction and planning. The person with dementia may lose the ability to perform familiar tasks, to plan activities, and to draw simple conclusions from facts.
  • Language and comprehension disturbances. The person may be unable to understand instructions, or follow the logic of moderately complex sentences. Later, he or she may not understand his or her own sentences, and have difficulty forming thoughts into words.
  • Poor judgment. The person may not recognize the consequences of his or her actions or be able to evaluate the appropriateness of behavior. Behavior may become crude or offensive, overly-friendly, or aggressive. Personal hygiene may be ignored.
  • Impaired orientation ability. The person may not be able to identify the time of day, even from obvious visual clues; or may not recognize his or her location, even if familiar. This disability may stem partly from losses of memory and partly from impaired abstraction.
  • Decreased attention and increased restlessness. This may cause the person with dementia to begin an activity and quickly lose interest, and to wander frequently. Wandering may cause significant safety problems, when combined with disorientation and memory losses. The person may begin to cook something on the stove, then become distracted and wander away while it is cooking.
  • Personality changes and psychosis. The person may lose interest in once-pleasurable activities, and become more passive, depressed, or anxious. Delusions, suspicion, paranoia, and hallucinations may occur later in the disease. Sleep disturbances may occur, including insomnia and sleep interruptions.

Diagnosis

Since dementia usually progresses slowly, diagnosing it in its early stages can be difficult. Several office visits over several months or more may be needed. Diagnosis begins with a thorough physical exam and complete medical history, usually including comments from family members or caregivers. A family history of either Alzheimer's disease or cerebrovascular disease may provide clues to the cause of symptoms. Simple tests of mental function, including word recall, object naming, and number-symbol matching, are used to track changes in the person's cognitive ability. Recent studies suggest that positron emissions tomography (PET) scans of the brain might be able to identify those at risk for Alzheimer's. As these tests become more widely available, they may offer hope for earlier detection of dementia.

Depression is common in the elderly and can be mistaken for dementia; therefore, ruling out depression is an important part of the diagnosis. Distinguishing dementia from the mild normal cognitive decline of advanced age is also critical. The medical history includes a complete listing of drugs being taken, since a number of drugs can cause dementia-like symptoms.

Determining the cause of dementia may require a variety of medical tests, chosen to match the most likely etiology. Cerebrovascular disease, hydrocephalus, and tumors may be diagnosed with x rays, CT or MRI scans, and vascular imaging studies. Blood tests may reveal nutritional or metabolic deficiencies or hormone imbalances.

Treatment

Nutritional Supplements

Some nutritional supplements may be helpful, especially if dementia is caused by deficiency of these essential nutrients:

  • Acetyl-L-carnitine: improves brain function and increases attention span, enhances ability to concentrate and increases energy in patients with Alzheimer's disease.
  • Antioxidants (vitamin E, vitamin C, beta-carotene, or selenium): may slow down disease progression by preventing the damaging effects of free radicals.
  • B-complex vitamins and vitamin B12: may significantly improve mental function in patients who have low levels of these essential nutrients.
  • Coenzyme Q10: helps deliver more oxygen to the brain
  • DHEA: may increase brain function in old people.
  • Magnesium: may be helpful if the dementia is caused by magnesium deficiency and/or accumulation of aluminum in the brain
  • Phosphotidylserine: Deficiency of this nutrient may decrease mental function and cause depression.
  • Zinc: may boost short-term memory and increase attention span

Herbal Treatment

Herbal remedies that may be helpful in treating dementia include Chinese or Korean ginseng, Siberian ginseng, gotu kola, and Ginkgo biloba. Of these, ginkgo biloba is the most well-known and widely accepted by Western medicine. Ginkgo extract, derived from the leaves of the Ginkgo biloba tree, interferes with a circulatory protein called platelet-activating factor. It also increases circulation and oxygenation to the brain. Ginkgo extract has been used for many years in China and is widely prescribed in Europe for treatment of circulatory problems. A 1997 study of patients with dementia appeared to show that gingko extract could improve their symptoms. Some scientists believe that, taken early enough in the process, Ginkgo biloba can delay the onset of Alzheimer's, but this claim has not yet been sufficiently backed by enough supportive studies.

Homeopathy

A homeopathic physician may prescribe patient-specific homeopathic remedies to alleviate symptoms of dementia.

Acupressure

This form of therapy uses hands to apply pressure on specific acupressure points to improve blood circulation and calm the nervous system.

Aromatherapy

Aromatherapists use essential oils as inhalants or in baths to improve mental performances and to calm the nerves.

Chelation Therapy

This is a controversial treatment that may provide symptomatic improvement in some patients. However, its effectiveness has not been supported by clinical studies. In addition, this form of therapy may cause kidney damage. Therefore, it should only be given under watchful eyes of a qualified physician.

Allopathic Treatment

There are no therapies that can reverse the progression of Alzheimer's disease. Therefore, treatment of dementia begins with treatment of the underlying disease when possible. Aspirin, estrogen, vitamin E, selegiline, propentofylline and milameline are currently being evaluated for their ability to slow the rate of progression.

Care for a person with dementia can be difficult and complex. The patient must learn to cope with functional and cognitive limitations, while family members or other caregivers assume increasing responsibility for the person's physical needs.

Symptoms of dementia may be treated with a combination of psychotherapy, environmental modifications and medication. Behavioral approaches may be used to reduce the frequency or severity of problem behaviors, such as aggression or socially inappropriate conduct.

Modifying the environment can increase safety and comfort while decreasing agitation. Home modifications for safety include removal or lock-up of hazards such as sharp knives, dangerous chemicals, and tools. Child-proof latches or Dutch doors may be used to limit access as well. Lowering the hot water temperature to 120°F (48.9°C) or less reduces the risk of scalding. Bed rails and bathroom safety rails can be important safety measures, as well. Confusion may be reduced with simpler decorative schemes and presence of familiar objects. Covering or disguising doors (with a mural, for example) may reduce the tendency to wander. Positioning the bed in view of the bathroom can decrease incontinence.

Two drugs, tacrine (Cognex) and donepezil (Aricept), are commonly prescribed for Alzheimer's disease. These drugs inhibit the breakdown of acetylcholine in the brain, prolonging its ability to conduct chemical messages between brain cells. They provide temporary improvement in cognitive functions for about 40% of patients with mild-to-moderate AD. Hydergine is sometimes prescribed as well, though it is of questionable benefit for most patients. Other drugs that are frequently used in dementia patients include antianxiety (for agitation and anxiety) and antipsychotics (for paranoia, delusions or hallucinations) and antidepressants (for depressive symptoms). Evaluation of any medical side effects from the medications should be ongoing.

Long-term institutional care may be needed for the person with dementia, as profound cognitive losses often precede death by a number of years. Early planning for the financial burden of nursing home care is critical. Useful information about financial planning for long-term care is available through the Alzheimer's Association.

Expected Results

The prognosis for dementia depends on the underlying disease. On average, people with Alzheimer's disease live eight years past their diagnosis, with a range from one to twenty years. Vascular dementia is usually progressive, with death from stroke, infection, or heart disease.

Prevention

There is no known way to prevent Alzheimer's disease, although several of the drugs under investigation may reduce its risk or slow its progression. Nutritional supplements, including antioxidants, may also help protect against Alzheimer's disease. New studies also show that use of nonsteroidal anti-inflammatory agents (overthe-counter pain relievers like ibuprofen and naproxen) may lower risk of Alzheimer's. The risk of developing multi-infarct dementia may be reduced by reducing the risk of stroke. Sources of aluminum, which can be found in aluminum cookware, canned sodas, and certain antacids and deodorants, should be avoided.

Resources

Books

Halpern, Georges. Ginkgo: A Practical Guide. Garden City Park, NY: Avery Publishing Group, 1998.

Jacques, Alan. Understanding Dementia. New York: Churchill Livingstone, 1992.

Mace, Nancy L. and Peter V. Rabins. The 36-Hour Day. Baltimore: Johns Hopkins University Press, 1995.

Murray, Michael and Joseph Pizzorno. "Alzheimer's Disease." In Encyclopedia of Natural Medicine. 2nd ed. Rocklin, CA: Prima Publishing, 1998.

Zand, Janet, Allan N. Spreen, and James B. LaValle. "Alzheimer's Disease." In Smart Medicine for Healthier Living: A Practical A-to-Z Reference to Natural and Conventional Treatments for Adults. Garden City Park, NY: Avery Publishing Group, 2000.

Periodicals

Gottlieb, Scott R."NSAIDs Can Lower Risk of Alzheimer's." British Medical Journal 323 no.7324 (December 1, 2001):1269.

Mitka M."PET and Memory Impairment." JAMA, Journal of the American Medical Association 286 no. 16 (October 24, 2001):1961.

Stephenson Joan. "Alzheimer Treatment Target?" JAMA, Journal of the American Medical Association 286 no. 14 (October 10, 2001):1704.

Organization

Alzheimer's Association. 919 North Michigan Ave., Suite 1000, Chicago, IL 60611. (800) 272-3900 (TDD: (312) 335-8882). http://www.alz.org/.

[Article by: Mai Tran; Teresa G. Odle]

Dementia is a condition characterized by a chronic decline in cognitive functions contrasted with a person's usual state of functioning. It is seen most often in people sixty-five years and older, and the incidence increases with age. Dementia occurs in a stable level of consciousness and sensorium, unlike delirium. There are various causes and types of dementia, but they have certain characteristics in common. Persons with dementia often have problems with short-term memory, such as forgetting names and recent events. They may have trouble with visuospatial processing, such as getting lost in familiar places. Language may be affected, causing difficulty in finding the right word to use in a sentence. The affected person may have difficulty with activities of daily living, such as balancing the checkbook or forgetting to turn off the stove when cooking. This condition may also be accompanied by alterations in personality and behavior. Persons with dementia often become depressed, irritable, or have unreasonable fears. They may also say or do inappropriate things in social situations. Visual or auditory hallucinations sometimes occur.

The onset of dementia is usually insidious. Recognition of the condition is often delayed due to lack of insight on the part of the affected person, who often does not notice that anything is wrong. Families are also slow to recognize the condition and sometimes deny that there is a problem. There is a common false myth that aging is synonymous with poor memory. Although aging results in mild slowing for some cognitive functions, normal aging does not cause significant memory loss. In many cases, the deterioration is progressive. However, some dementias have reversible causes, and this possibility must be investigated thoroughly when the person comes for treatment. Physicians should regularly screen patients who are sixty-five years and older for dementia.

Alzheimer's disease is the most common type of dementia in North America and Europe (50–60 percent of dementias). It is characterized by slow onset and gradual impairment of recent memory. Long-term memory usually remains more intact. This impairment progresses until death. It is thought to be caused by the accumulation of certain proteins in the brain. It is not clear what causes this condition to occur. Alzheimer's disease is usually diagnosed clinically by cognitive testing rather than using laboratory tests.

Dementia may also be caused by problems with the vascular system, such as cerebrovascular accident (stroke), hypertension, and atherosclerosis. This is thought to make up 15 to 20 percent of dementias in North America and Europe. These disorders are characterized by abrupt onset of cognitive dysfunction that progressively worsens in a step-wise pattern as multiple strokes recur and damage to the brain accumulates.

There are many other causes of dementia, including trauma, metabolic imbalances, hereditary illness, drugs (e.g., alcohol), toxins, and infections (e.g., HIV [human immunodeficiency virus], syphilis). Some of these causes are reversible with medical treatment. Unlike Alzheimer's disease, these conditions usually have rapid onset and progression. Whenever dementia is diagnosed, these reversible causes must be ruled out promptly.

Parkinson's disease is a movement disorder characterized by tremor, slow unsteady gait, and a mask-like face. Decreased levels of a chemical called dopamine in the brain cause this condition. Approximately 30 percent of persons with Parkinson's disease also have dementia. This dementia is characterized by fluctuations in alertness and cognitive abilities. It is also associated with visual hallucinations. It can be treated with medications that increase the levels of dopamine in the brain.

Psychiatric disorders like depression may cause a dementia-like impairment of memory and concentration called pseudodementia. Depression is a common condition in the elderly. People with depression often have problems with sleep, guilt, appetite, sexual drive, low mood, low energy, and loss of interest in activities, and they may be suicidal. They are more likely to be pessimistic and complain of poor memory than a person with true Alzheimer's disease, who usually tries to deny any problems. Pseudodementia improves after the depression is treated, usually by psychotherapy, medications, or social support. Depression may occur in some individuals with dementia as the person becomes aware of the cognitive decline. Treatment of depression may still be very helpful in such cases.

Diagnosis of dementia requires a thorough physical, neurological, and psychiatric exam. Neuropsychological testing consists of a battery of cognition tests and helps determine what functions are specifically impaired. Laboratory tests are required as part of the medical evaluation. Occasionally, brain imaging is used if a brain tumor or head injury is suspected.

(SEE ALSO: Alzheimer's Disease; Stroke)

Bibliography

Kaplan, H., and Sadock, B., eds. (1995). Comprehensive Textbook of Psychiatry, Vol. 1, 6th edition. Baltimore, MD: Williams and Willkins.

Knopman, D. (1998). "The Initial Recognition and Diagnosis of Dementia." The American Journal of Medicine 104 (April):2S–12S.

Tierney L.; McPhee, S.; and Papadakis, M. (1999). "Dementia." In Current Medical Diagnosis and Treatment, 38th edition. Stamford, CT: Appleton and Lange.

— BETTY TZENG; STUART J. EISENDRATH



 
Columbia Encyclopedia: dementia
Top
dementia (dĭmĕn'shə) [Lat.,=being out of the mind], progressive deterioration of intellectual faculties resulting in apathy, confusion, and stupor. In the 17th cent. the term was synonymous with insanity, and the term dementia praecox was used in the 19th cent. to describe the condition now known as schizophrenia. In recent years, the term has generally been used to describe various conditions of mental deterioration occurring in middle to later life. Dementia, in its contemporary usage, is an irreversible condition, and is not applied to states of mental deterioration that may be overcome, such as delirium. The condition is generally caused by deterioration of brain tissue, though it can occassionally be traced to deterioration of the circulatory system. Major characteristics include short- and long-term memory loss, impaired judgement, slovenly appearance, and poor hygiene. Dementia disrupts personal relationships and the ability to function occupationally. Senility (senile dementia) in old age is the most commonly recognized form of dementia, usually occurring after the age of 65. Alzheimer's disease can begin at a younger age, and deterioration of the brain tissue tends to happen much more quickly. Individuals who have experienced cerebrovascular disease (particularly strokes) may develop similar brain tissue deterioration, with symptoms similar to Alzheimer's disease and senile dementia. Other types of dementia include Huntington's disease, Parkinson's disease, and Pick's disease. Some forms of familial Alzheimer's disease are caused by specific dominant gene mutations.

Bibliography

See L. L. Heston and J. White, The Vanishing Mind (1991).


Psychoanalysis: Dementia
Top

Dementia has been defined in two very different ways. The first definition, which came into use in the nineteenth century with the establishment of a nosographic framework for the psychoses, culminated in the concept of dementia praecox in the work of Emil Kraepelin. The second definition concerns altered states in memory and ideation following injury to the brain.

The word dementia, which first appeared in a psychiatric sense in Philippe Pinel's work contrasting mania and dementia, underwent changes in meaning during the nineteenth century. In 1911 Eugen Bleuler, in his discussion of the concept of schizophrenia, centered around dissociation or splitting (Spaltung), proposed bringing together the old notion of "vesanic dementia" (the culmination of psychotic development) and Kraepelin's three forms of dementia praecox: hebephrenic, catatonic, and paranoid.

Sigmund Freud approved of Kraepelin's approach but he criticized the term dementia praecox, as well as the term schizophrenia. This despite the fact that he felt it important to distinguish between the two, writing, in "Psycho-Analytical Notes on an Autobiographical Account of a Case of Paranoia (Dementia Paranoides)" (1911 c[1910]): ". . . we shall hope later on to find clues which will enable us to trace back the differences between the two disorders (as regards both the form they take and the course they run) to corresponding differences in the patients' dispositional fixations" (p. 62). In reality, he continued to use both terms indiscriminately. He focused his study of the psychoses on paranoia in the essay cited above. After "On Narcissism: An Introduction," (1914) he proposed to distinguish among the neuroses, the psychoses, and the perversions. In Freudian theory, dementia praecox consists of a withdrawal of object libido onto the ego through regression and fixation. Freud later went on to specify its linguistic characteristics (words are subjected to the primary process) and its functioning (reality testing is no longer operant; verbal delusions are an attempt at healing), but essentially it was Freud's successors who developed a psychoanalytic theory of the psychoses.

In current usage, the term dementia refers to erosion of the intelligence caused by many different kinds of damage to the brain: degenerative dementias (dominated by Alzheimer's disease), vascular diseases, infectious diseases, toxic conditions, or metabolic disorders. Clinical treatment of dementia from a psychoanalytic perspective runs up against problems of theoretical elaboration. Psychoanalysis has limited applications for these conditions and is used mainly in the early stages of illness. The goal is to limit the breakdown of identity for a certain time. The gradual erosion of the capacity for symbolization and the work of representation owing to memory loss, the weakening of repression and the breaking through of the protective shield, and the instinctual flooding that ensues, has led to reliance on a therapeutic approach focusing on the reconstitutive function of the affects as the basis for mental activity, since, as Michèle Grosclaude suggested in Le Statut de l'affect dans la psychothérapie des démences (The status of the affects in the psychotherapy of dementia; 1997), verbal therapies are among the first to be affected by the degenerative process. Denial, projective delusions, and heightened anxiety are all typical of these conditions.

Bibliography

Freud, Sigmund. (1911c [1910]). Psycho-analytical notes on autobiographical account of a case of paranoia (dementia paranoides). SE, 12, 9-82.

——. (1914). On narcissism: an introduction. SE, 14, 73-102.

——. (1915). The unconscious. SE, 14, 166-204.

Grosclaude, Michèle. (1997). Le Statut de l'affect dans la psychothérapie des démences. Psychothérapie des démences. Montrouge, France: John Libbey Eurotext.

—RICHARD UHL

World of the Mind: dementia
Top
This is defined by W. A. Lishman (1978) as 'an acquired global impairment of intellect, memory, and personality but without impairment of consciousness'. Although often considered to be an irreversible condition, recent studies have shown that about 10 per cent of patients with dementia have conditions for which treatment can reverse the otherwise inexorable decline of mental function. The progressive dementias are most often diagnosed in the elderly under the headings of senile dementia of the Alzheimer type and multi-infarct dementia. The former is caused by widespread degeneration of nerve cells in the brain and their replacement by elements known as plaques and neurofibrillary tangles. Post-mortem studies of the brains of patients who have died from senile dementia have enabled correlation of the numbers of these elements with the degree of mental impairment shown by psychometric testing during life. Multi-infarct dementia, which is less common than senile dementia, is caused by loss of brain substance following repeated closure of small or large blood vessels, incidents that cause minor or major strokes. The older term, arteriosclerotic dementia, has now been superseded.

These areas of degeneration may be widespread and scattered, or concentrated in certain areas of the brain. If the latter, the mental changes will be much more severe in some functions than in others. For instance, the person may lose his speech (developing aphasia) but not his memory, or vice versa. One of the last things usually to be affected is his basic personality, and some of the last skills to be lost are the social ones. Hence some demented persons will retain the major features of personality, remaining well mannered, considerate, and responsive if these were the former characteristics. On the other hand, blunting of emotion and loss of control of social behaviour may lead to episodes of petulant and irritable behaviour or tactless and inappropriate remarks which would not have been uttered before the onset of the illness.

The difference between dementia and the more limited losses of mental ability due to focal injuries is that the demented person can seldom make compensations for his disabilities in the way the others do, and, indeed, very often seems to be unaware of them. He tends to live his life entirely for the present moment, although the present for him may be an era from his own distant past.

Although it is characteristic of the truly demented person that he has little insight into his defects, inability to cope with his environment may make him severely perplexed, or trigger off a condition described by Kurt Goldstein (1878–1965) and called by him the 'catastrophic reaction'. The individual becomes tearful and angry; he may repeat non-adaptive stereotyped movements in a repetitive manner, or start sweating and becoming restless. The 'emotional lability' that accompanies dementia is one of its outstanding characteristics and helps to differentiate it from true depression, in which the individual remains sad and retarded no matter how his circumstances alter. Dementia must also be differentiated from another, much less common form of emotional disorder: that accompanying bulbar palsy, in which the individual may respond to any sudden stimulus or strong effort by screwing up his face and bursting into tears, without any of the unhappiness that usually causes such outbursts. 'I just can't help crying,' he may be able to tell you between spasms. 'Don't pay any attention to me.' In contrast to both of these, the emotional state of the demented person seems to reflect exactly the situation of the moment. If he is faced with a problem too difficult for him to solve, he shows all the signs of distress, but if this is removed and he is presented with a simpler one, the next moment he will be laughing and cheerful. It follows that even severe dementia may not necessarily cause its sufferer any personal pain, depending on where and how he is cared for. If his environment is simple, cheerful, and constant (i.e. unchanging) he may to all outward appearances (and on his own admission) be perfectly cheerful and contented.

It is important to distinguish dementia from the other disorders which commonly affect the elderly, as, although there is, as yet, no known method of retarding or reversing dementia, many of the other conditions are fully treatable. In the speech disorders of dementia, comprehension is usually just as badly affected as expression, whereas in the aphasia due to focal lesions this is very rare. Moreover, the errors made when trying to name objects are rather different. The aphasic person usually manages to indicate that he knows perfectly well what the object is even though he cannot find its name, but the demented person often seems to fail to recognize the object too. If asked to name different parts of his body, the aphasic person can usually name those parts that are commonly mentioned (such as feet, hands, and arms) but not those less frequently so (knuckles, eyebrows, ankles); in the demented there is seldom any difference.

The failure of memory seen in senile dementia is also different from that seen in normal old age (see ageing) or in the organic amnesic conditions. In the latter, cues or prompts very often help, but in the demented they seem rather to do the opposite. If one considers recall as being like searching for an item in a vast territory, a cue for the amnesic narrows the field of search and directs his attention to a specific area; for the demented, it seems to direct him to a new part of the field. For instance, if the target is the word 'cart', a useful cue for an amnesic would be the words 'Horse and — — '. A case of senile dementia might respond by saying, 'Horse? Yes, I remember we had many horses when I was a child, one particular one ... '.

The ability to handle and manipulate objects is usually little impaired in dementia. Those motor skills which were learned in the past are well retained, but since he is inclined to forget what he is aiming to achieve before he has half done it, the demented person gets himself into difficulties. At first appearance he may seem to be suffering from apraxia (the loss of such skills due to focal lesions), but closer study will reveal differences. For example, both apraxic and demented individuals often have difficulty dressing themselves, but in the case of the apraxic the difficulty is due to 'forgetting' how to tie knots, do up buttons, or put an arm into a sleeve; in the demented it is due to forgetting whether he is supposed to be getting dressed or undressed at the time. When preparing meals — even such a simple task as making a pot of tea — the apraxic forgets how to put tea into the pot or stir it with a spoon; the demented can do all these things, if reminded constantly of the task in hand, but if distracted at all is liable to lose track of how far he has got and has to start from the beginning again.

Finally, there are two conditions that may be easily mistaken for dementia. The first is a severe depressive illness which may produce the condition sometimes called pseudodementia which only a skilled psychiatrist can distinguish from true dementia, but which responds to appropriate antidepressant treatment. The second is a delirious state, triggered off in an old person by physical disorder such as pneumonia, a heart attack, or hypothermia. Unlike dementia, which usually comes on slowly over a long period, delirious states are likely to appear suddenly and will be accompanied by severe disorientation and even hallucinations. These symptoms, however, clear up completely once the underlying physical disorder is rectified, and in former days it was quite common for an old person to 'wake up' after such an illness and find himself in a mental hospital labelled, to his great consternation, a case of senile dementia.

(Published 1987)

— Moyra Williams

    Bibliography
  • Lishman, W. A. (1978). Organic Psychiatry.
  • Miller, E. (1977). Abnormal Ageing.
  • Ritchie, K., and Lovestone, S. (2002). 'The dementias'. Lancet, 360.
  • Roth, M., and Iverson, L. L. (eds.) (1986). 'Alzheimer's disease and related disorders'. British Medical Bulletin, 42.
  • Williams, M. (1979). Brain Damage, Behaviour and the Mind.


Veterinary Dictionary: dementia
Top

Loss of intellectual capacity accompanied usually by irrational behavior.

 
Blogs: Related blogs on: dementia
Top

Wikipedia: Dementia
Top
Dementia
Classification and external resources
ICD-10 F00.-F07.
ICD-9 290-294
DiseasesDB 29283
MedlinePlus 000739
MeSH D003704

Dementia (meaning "deprived of mind") is a serious cognitive disorder. It may be static, the result of a unique global brain injury or progressive, resulting in long-term decline in cognitive function due to damage or disease in the body beyond what might be expected from normal aging. Although dementia is far more common in the geriatric population, it may occur in any stage of adulthood. This age cutoff is defining, as similar sets of symptoms due to organic brain syndrome or dysfunction, are given different names in populations younger than adult. Up to the end of the nineteenth century, dementia was a much broader clinical concept.[1]

Dementia is a non-specific illness syndrome (set of signs and symptoms) in which affected areas of cognition may be memory, attention, language, and problem solving. It is normally required to be present for at least 6 months to be diagnosed;[2] cognitive dysfunction that has been seen only over shorter times, in particular less than weeks, must be termed delirium. In all types of general cognitive dysfunction, higher mental functions are affected first in the process. Especially in the later stages of the condition, affected persons may be disoriented in time (not knowing what day of the week, day of the month, or even what year it is), in place (not knowing where they are), and in person (not knowing who they are or others around them). Dementia, though often treatable to some degree, is usually due to causes that are progressive and incurable.[citation needed]

Symptoms of dementia can be classified as either reversible or irreversible, depending upon the etiology of the disease. Less than 10 percent of cases of dementia are due to causes that may presently be reversed with treatment. Causes include many different specific disease processes, in the same way that symptoms of organ dysfunction such as shortness of breath, jaundice, or pain are attributable to many etiologies. Without careful assessment of history, the short-term syndrome of delirium (often lasting days to weeks) can easily be confused with dementia, because they have all symptoms in common, save duration, and the fact that delirium is often associated with over-activity of the sympathetic nervous system.[citation needed] Some mental illnesses, including depression and psychosis, may also produce symptoms that must be differentiated from both delirium and dementia.[3] Chronic use of substances such as alcohol as well as chronic sleep deprivation can also predispose the patient to cognitive changes suggestive of dementia.

Contents

Signs and symptoms

Comorbidities

Dementia is not merely a problem of memory. Additional mental and behavioral problems often affect people who have dementia, and may influence quality of life, caregivers, and the need for institutionalization.

Depression affects 20-30% of people who have dementia, and about 20% have anxiety.[4] Psychosis (often delusions of persecution) and agitation/aggression also often accompany dementia. Each of these needs to be assessed and treated independent of the underlying dementia.[5]

Risk to self and others

The Canadian Medical Association Journal has reported that driving with dementia could lead to severe injury or even death to self and others. Doctors should advise appropriate testing on when to quit driving.[6]

In the United States, Florida's Baker Act allows law enforcement and the judiciary to force mental evaluation for those suspected of suffering from dementia or other mental incapacities.[citation needed]

In the United Kingdom, as with all mental disorders, where a sufferer could potentially be a danger to themselves or others, they can be detained under the Mental Health Act 1983 for the purposes of assessment, care and treatment. This is a last resort, and usually avoided if the patient has family or friends who can ensure care.

The United Kingdom DVLA (Driving & Vehicle Licensing Agency) states that Dementia sufferers who specifically suffer with poor short term memory, disorientation, lack of insight or judgement are almost certainly not fit to drive - and in these instances, the DVLA must be informed so said license can be revoked. They do however acknowledge low-severity cases and early sufferers, and those drivers may be permitted to drive pending medical report.

Diagnosis

Proper differential diagnosis between the types of dementia (cortical and subcortical - see below) will require, at the least, referral to a specialist, e.g., a geriatric internist, geriatric psychiatrist, neurologist, neuropsychologist or geropsychologist.[citation needed] However, there exist some brief tests (5–15 minutes) that have reasonable reliability and can be used in the office or other setting to screen cognitive status for deficits that are considered pathological. Examples of such tests include the abbreviated mental test score (AMTS), the mini mental state examination (MMSE), Modified Mini-Mental State Examination (3MS),[7] the Cognitive Abilities Screening Instrument (CASI),[8] and the clock drawing test.[9] An AMTS score of less than six (out of a possible score of ten) and an MMSE score under 24 (out of a possible score of 30) suggests a need for further evaluation. Scores must be interpreted in the context of the person's educational and other background, and the particular circumstances; for example, a person highly depressed or in great pain will not be expected to do well on many tests of mental ability.

Mini-mental state examination

The U.S. Preventive Services Task Force (USPSTF) reviewed tests for cognitive impairment and concluded:[10]

  • MMSE
sensitivity 71% to 92%
specificity 56% to 96%

Modified Mini-Mental State examination (3MS)

A copy of the 3MS is online.[11] A meta-analysis concluded that the Modified Mini-Mental State (3MS) examination has:[12]

sensitivity 83% to 93.5%
specificity 85% to 90%

Abbreviated mental test score

A meta-analysis concluded:[12]

sensitivity 73% to 100%
specificity 71% to 100%

Duration of symptoms

Duration of symptoms must normally exceed 6 months for a diagnosis of dementia or organic brain syndrome to be made.

Other examinations

Many other tests have been studied[13][14][15] including the clock-drawing test (example form). Although some may emerge as better alternatives to the MMSE, presently the MMSE is the best studied. However, access to the MMSE is now limited by enforcement of its copyright.[citation needed]

Another approach to screening for dementia is to ask an informant (relative or other supporter) to fill out a questionnaire about the person's everyday cognitive functioning. Informant questionnaires provide complementary information to brief cognitive tests. Probably the best known questionnaire of this sort is the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE).[16]

The General Practitioner Assessment Of Cognition combines both, a patient assessment and an informant interview. It was specifically designed for the use in the primary care setting and is also available as web-based test. It can be accessed on www.gpcog.com.au.

Further evaluation includes retesting at another date, and administration of other (and sometimes more complex) tests of mental function, such as formal neuropsychological testing.

Laboratory tests

Routine blood tests are also usually performed to rule out treatable causes. These tests include vitamin B12, folic acid, thyroid-stimulating hormone (TSH), C-reactive protein, full blood count, electrolytes, calcium, renal function, and liver enzymes. Abnormalities may suggest vitamin deficiency, infection or other problems that commonly cause confusion or disorientation in the elderly. The problem is complicated by the fact that these cause confusion more often in persons who have early dementia, so that "reversal" of such problems may ultimately only be temporary.[citation needed]

Testing for alcohol and other known dementia-inducing drugs may be indicated.

Imaging

A CT scan or magnetic resonance imaging (MRI scan) is commonly performed, although these modalities do not have optimal sensitivity for the diffuse metabolic changes associated with dementia in a patient that shows no gross neurological problems (such as paralysis or weakness) on neurological exam. CT or MRI may suggest normal pressure hydrocephalus, a potentially reversible cause of dementia, and can yield information relevant to other types of dementia, such as infarction (stroke) that would point at a vascular type of dementia.

The functional neuroimaging modalities of SPECT and PET are more useful in assessing long-standing cognitive dysfunction, since they have shown similar ability to diagnose dementia as a clinical exam.[17] The ability of SPECT to differentiate the vascular cause from the Alzheimer disease cause of dementias, appears to be superior to differentiation by clinical exam.[18]

Recent research has established the value of PET imaging using carbon-11 Pittsburgh Compound B as a contrast medium (PIB-PET) in predictive diagnosis of various kinds of dementia, in particular Alzheimer's disease. Studies from Australia have found PIB-PET to be 86% accurate in predicting which patients with mild cognitive impairment would develop Alzheimer's disease within two years. In another study, carried out using 66 patients seen at the University of Michigan, PET studies using either PIB or another contrast agent, carbon-11 dihydrotetrabenazine (DTBZ), led to more accurate diagnosis for more than one-fourth of patients with mild cognitive impairment or mild dementia.[19]

Causes

Fixed cognitive impairment

Various types of brain injury, occurring as a single event, may cause irreversible but fixed cognitive impairment. Traumatic brain injury may cause generalised damage to the white matter of the brain (diffuse axonal injury), or more localised damage (as also may neurosurgery). A temporary reduction in the brain's supply of blood or oxygen may lead to hypoxic-ischemic injury. Strokes (ischemic stroke, or intracerebral, subarachnoid, subdural or extradural hemorrhage) or infections (meningitis and/or encephalitis) affecting the brain, prolonged epileptic seizures and acute hydrocephalus may also have long-term effects on cognition. Excessive alcohol use may cause either alcohol dementia or Korsakoff's psychosis (and certain other recreational drugs may cause substance-induced persisting dementia); once overuse ceases, the cognitive impairment is persistent but non-progressive.

Slowly progressive dementia

Dementia which begins gradually and worsens progressively over several years is usually caused by neurodegenerative disease, that is, by conditions affecting only or primarily the neurons of the brain and causing gradual but irreversible loss of function of these cells. Less commonly, a non-degenerative condition may have secondary effects on brain cells, which may or may not be reversible if the condition is treated.

The causes of dementia depend on the age at which symptoms begin. In the elderly population (usually defined in this context as over 65 years of age), a large majority of cases of dementia are caused by Alzheimer's disease, vascular dementia or both. Dementia with Lewy bodies is another fairly common cause, which again may occur alongside either or both of the other causes[20][21][22]. Hypothyroidism sometimes causes slowly progressive cognitive impairment as the main symptom, and this may be fully reversible with treatment. Normal pressure hydrocephalus, though relatively rare, is important to recognise since treatment may prevent progression and improve other symptoms of the condition. However, significant cognitive improvement is unusual.

Dementia is much less common under 65 years of age. Alzheimer's disease is still the most frequent cause, but inherited forms of the disease account for a higher proportion of cases in this age group. Frontotemporal lobar degeneration and Huntington's disease account for most of the remaining cases[23]. Vascular dementia also occurs, but this in turn may be due to underlying conditions (including antiphospholipid syndrome, CADASIL, MELAS, homocystinuria, moyamoya and Binswanger's disease). People who receive frequent head trauma, such as boxers or some martial artists, are at risk of dementia pugilistica. An association between coeliac disease and dementia has been proposed, but this is controversial.

In young adults (up to 40 years of age) who were previously of normal intelligence, it is very rare to develop dementia without other features of neurological disease, or without features of disease elsewhere in the body. Most cases of progressive cognitive disturbance in this age group are caused by psychiatric illness, alcohol or other drugs, or metabolic disturbance. However, certain genetic disorders can cause true neurodegenerative dementia at this age. These include familial Alzheimer's disease, metachromatic leukodystrophy, SCA17 (dominant inheritance); adrenoleukodystrophy (X-linked); Gaucher's disease type 3, Niemann-Pick disease type C, pantothenate kinase-associated neurodegeneration, Tay-Sachs disease and Wilson's disease (all recessive). Wilson's disease is particularly important since cognition can improve with treatment.

At all ages, a substantial proportion of patients who complain of memory difficulty or other cognitive symptoms are suffering from depression rather than a neurodegenerative disease. Vitamin deficiencies and chronic infections may also occur at any age; they usually cause other symptoms before dementia occurs, but occasionally mimic degenerative dementia. These include deficiencies of vitamin B12, folate or niacin, and infective causes including cryptococcal meningitis, HIV, Lyme disease, progressive multifocal leukoencephalopathy, subacute sclerosing panencephalitis, syphilis and Whipple's disease.

Rapidly progressive dementia

Creutzfeldt-Jakob disease typically causes a dementia which worsens over weeks to months. The common causes of slowly progressive dementia also sometimes present with rapid progression: Alzheimer's disease, dementia with Lewy bodies, frontotemporal lobar degeneration (including corticobasal degeneration and progressive supranuclear palsy).

On the other hand, encephalopathy or delirium may develop relatively slowly and resemble dementia. Possible causes include brain infection (viral encephalitis, subacute sclerosing panencephalitis, Whipple's disease) or inflammation (limbic encephalitis, Hashimoto's encephalopathy, cerebral vasculitis); tumours such as lymphoma or glioma; drug toxicity (e.g. anticonvulsant drugs); metabolic causes such as liver failure or kidney failure; and chronic subdural hematoma.

Dementia as a feature of other conditions

There are many other medical and neurological conditions in which dementia only occurs late in the illness, or as a minor feature. For example, a proportion of patients with Parkinson's disease develop dementia, though widely varying figures are quoted for this proportion[citation needed]. When dementia occurs in Parkinson's disease, the underlying cause may be dementia with Lewy bodies or Alzheimer's disease, or both[24]. Cognitive impairment also occurs in the Parkinson-plus syndromes of progressive supranuclear palsy and corticobasal degeneration (and the same underlying pathology may cause the clinical syndromes of frontotemporal lobar degeneration). Chronic inflammatory conditions of the brain may affect cognition in the long term, including Behçet's disease, multiple sclerosis, sarcoidosis, Sjögren's syndrome and systemic lupus erythematosus. Although the acute porphyrias may cause episodes of confusion and psychiatric disturbance, dementia is a rare feature of these rare diseases[25].

Aside from those mentioned above, inherited conditions which may cause dementia alongside other features include[26]:

Prevention

It appears that the regular moderate consumption of alcohol (beer, wine, or distilled spirits) and a Mediterranean diet may reduce risk.[27][28][29][30] A study has shown a link between high blood pressure and developing dementia. The study, published in the Lancet Neurology journal July 2008, found that blood pressure lowering medication reduced dementia by 13%.[31][32]

Brain-derived neurotrophic factor (BDNF) expression is associated with some dementia types.[33][34][35]

NSAIDs

Non-steroidal anti-inflammatory drugs (NSAIDs) can decrease the risk of developing Alzheimer's and Parkinson's diseases.[36] The length of time needed to prevent dementia varies, but in most studies it is usually between 2 and 10 years.[37][38][39][40][41] Research has also shown that it must be used in clinically relevant dosages and that so called "baby aspirin" doses are ineffective at preventing and treating dementia.[42]

Alzheimer's disease causes inflammation in the neurons by its deposits of amyloid beta peptides and neurofibrillary tangles. These deposits irritate the body by causing a release of e.g. cytokines and acute phase proteins, leading to inflammation. When these substances accumulate over years they contribute to the effects of Alzheimer's.[43] NSAIDs inhibit the formation of such inflammatory substances, and prevent the deteriorating effects.[44][45][46]

Management

Except for the treatable types listed above, there is no cure to this illness, although scientists are progressing in making a type of medication that will slow down the process.[citation needed] Cholinesterase inhibitors are often used early in the disease course. Cognitive and behavioral interventions may also be appropriate. Educating and providing emotional support to the caregiver (or carer) is of importance as well (see also elderly care).

A Canadian study found that a lifetime of bilingualism has a marked influence on delaying the onset of dementia by an average of four years when compared to monolingual patients. The researchers determined that the onset of dementia symptoms in the monolingual group occurred at the mean age of 71.4, while the bilingual group was 75.5 years. The difference remained even after considering the possible effect of cultural differences, immigration, formal education, employment and even gender as influences in the results.[47]

Some studies worldwide have found that Music therapy may be useful in helping patients with dementia.[48][49][50][51][52]

Medications

Tacrine (Cognex), donepezil (Aricept), galantamine (Razadyne), and rivastigmine (Exelon) are approved by the United States Food and Drug Administration (FDA) for treatment of dementia induced by Alzheimer disease. They may be useful for other similar diseases causing dementia such as Parkinsons or vascular dementia.[53]

  • N-methyl-D-aspartate Blockers. Memantine (Namenda) is a drug representative of this class. It can be used in combination with acetylcholinesterase inhibitors.[54][55]

Off label

  • Amyloid deposit inhibitors

Minocycline and Clioquinoline, antibiotics, may help reduce amyloid deposits in the brains of persons with Alzheimer disease.[56]

Depression is frequently associated with dementia and generally worsens the degree of cognitive and behavioral impairment. Antidepressants effectively treat the cognitive and behavioral symptoms of depression in patients with Alzheimer's disease,[57] but evidence for their use in other forms of dementia is weak.[58]

Many patients with dementia experience anxiety symptoms. Although benzodiazepines like diazepam (Valium) have been used for treating anxiety in other situations, they are often avoided because they may increase agitation in persons with dementia and are likely to worsen cognitive problems or are too sedating. Buspirone (Buspar) is often initially tried for mild-to-moderate anxiety.[citation needed] There is little evidence for the effectiveness of benzodiazepines in dementia, whereas there is evidence for the effectivess of antipsychotics (at low doses).[59]

Selegiline, a drug used primarily in the treatment of Parkinson's disease, appears to slow the development of dementia. Selegiline is thought to act as an antioxidant, preventing free radical damage. However, it also acts as a stimulant, making it difficult to determine whether the delay in onset of dementia symptoms is due to protection from free radicals or to the general elevation of brain activity from the stimulant effect.[60]

  • Antipsychotic drugs

Both typical antipsychotics (such as Haloperidol) and atypical antipsychotics such as (risperidone) increases the risk of death in dementia-associated psychosis.[61] This means that any use of antipsychotic medication for dementia-associated psychosis is off-label and should only be considered after discussing the risks and benefits of treatment with these drugs, and after other treatment modalities have failed. In the UK around 144,000 dementia sufferers are unnecessarily prescribed antipsychotic drugs , around 2000 patients die as a result of taking the drugs each year.[62]

Services

Adult daycare centers as well as special care units in nursing homes often provide specialized care for dementia patients. Adult daycare centers offer supervision, recreation, meals, and limited health care to participants, as well as providing respite for caregivers.

Epidemiology

Disability-adjusted life year for Alzheimer and other dementias per 100,000 inhabitants in 2002.
     no data      ≤ 50      50-70      70-90      90-110      110-130      130-150      150-170      170-190      190-210      210-230      230-250      ≥ 250

See also

References

Notes

  1. ^ Berrios GE (November 1987). "Dementia during the seventeenth and eighteenth centuries: a conceptual history". Psychological Medicine 17 (4): 829–37. doi:10.1017/S0033291700000623. ISSN 0033-2917. PMID 3324141. 
  2. ^ "Dementia definition". MDGuidelines. Reed Group. http://www.mdguidelines.com/dementia/definition. Retrieved 2009-06-04. 
  3. ^ Gleason OC (March 2003). "Delirium". American Family Physician 67 (5): 1027–34. PMID 12643363. http://www.aafp.org/afp/20030301/1027.html. Retrieved 2009-06-04. 
  4. ^ Calleo J, Stanley M (2008). "[http://www.psychiatrictimes.com/display/article/10168/1166976 Anxiety Disorders in Later Life Differentiated Diagnosis and Treatment Strategies]". Psychiatric Times 25 (8). http://www.psychiatrictimes.com/display/article/10168/1166976. 
  5. ^ Shub, Denis; Kunik, Mark E (April 16, 2009). "Psychiatric Comorbidity in Persons With Dementia: Assessment and Treatment Strategies". Psychiatric Times 26 (4). http://www.psychiatrictimes.com/alzheimer-dementia/article/10168/1403050. 
  6. ^ Drivers with dementia a growing problem, MDs warn, CBC News, Canada, September 19, 2007
  7. ^ Teng EL, Chui HC (August 1987). "The Modified Mini-Mental State (3MS) examination". The Journal of Clinical Psychiatry 48 (8): 314–8. ISSN 0160-6689. PMID 3611032. 
  8. ^ Teng EL, Hasegawa K, Homma A, et al. (1994). "The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia". International Psychogeriatrics / IPA 6 (1): 45–58; discussion 62. doi:10.1017/S1041610294001602. PMID 8054493. 
  9. ^ Royall, D; Cordes, J.; Polk, . M. (1998). "CLOX: an executive clock drawing task". J Neurol Neurosurg Psychiatry 64 (5): 588–94. doi:10.1136/jnnp.64.5.588. PMID 9598672. http://jnnp.bmj.com/cgi/content/full/64/5/588. 
  10. ^ Boustani, M; Peterson, B; Hanson, L; Harris, R; & Lohr, K (03 Jun 2003). "Screening for dementia in primary care: a summary of the evidence for the U.S. Preventive Services Task Force". Ann Intern Med 138 (11): 927–37. PMID 12779304. http://www.annals.org/cgi/content/full/138/11/927. 
  11. ^ "Appendix: The Modified Mini-Mental State (3MS)". http://www.cjns.org/27febtoc/predicting_appendix_.html. Retrieved 2007-09-06. 
  12. ^ a b Cullen B, O'Neill B, Evans JJ, Coen RF, Lawlor BA (August 2007). "A review of screening tests for cognitive impairment". Journal of Neurology, Neurosurgery, and Psychiatry 78 (8): 790–9. doi:10.1136/jnnp.2006.095414. PMID 17178826. 
  13. ^ Sager MA, Hermann BP, La Rue A, Woodard JL (October 2006). "Screening for dementia in community-based memory clinics" (PDF). WMJ : Official Publication of the State Medical Society of Wisconsin 105 (7): 25–9. PMID 17163083. http://www.wisconsinmedicalsociety.org/_WMS/publications/wmj/issues/wmj_v105n7/sager.pdf. Retrieved 2009-06-04. 
  14. ^ Fleisher, A; Sowell, B.; Taylor, C.; Gamst, A.; Petersen, R.; Thal, . L. (2007). "Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment". Neurology 68 (19): 1588. doi:10.1212/01.wnl.0000258542.58725.4c. PMID 17287448. 
  15. ^ Karlawish, J. & Clark, C. (2003). "Diagnostic evaluation of elderly patients with mild memory problems". Ann Intern Med 138 (5): 411–9. PMID 12614094. http://www.annals.org/cgi/content/full/138/5/411. 
  16. ^ Jorm AF (September 2004). "The Informant Questionnaire on cognitive decline in the elderly (IQCODE): a review". International Psychogeriatrics / IPA 16 (3): 275–93. doi:10.1017/S1041610204000390. PMID 15559753. 
  17. ^ Bonte, FJ; Harris TS, Hynan LS, Bigio EH, White CL 3rd (July 2006). "Tc-99m HMPAO SPECT in the differential diagnosis of the dementias with histopathologic confirmation". Clinical Nuclear Medicine 31 (7): 376–8. doi:10.1097/01.rlu.0000222736.81365.63. PMID 16785801. 
  18. ^ Dougall, NJ; Bruggink S, Ebmeier KP (Nov-December 2004). "Systematic review of the diagnostic accuracy of 99mTc-HMPAO-SPECT in dementia". The American Journal of Geriatric Psychiatry 12 (6): 554–70. doi:10.1176/appi.ajgp.12.6.554. PMID 15545324. 
  19. ^ Abella HA (June 16, 2009). "Report from SNM: PET imaging of brain chemistry bolsters characterization of dementias". Diagnostic Imaging. http://www.diagnosticimaging.com/imaging-trends-advances/cardiovascular-imaging/article/113619/1423022. 
  20. ^ "Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS)". Lancet 357 (9251): 169-75. 2001. PMID 11213093. 
  21. ^ Wakisaka Y et al. (2003). "Age-associated prevalence and risk factors of Lewy body pathology in a general population: the Hisayama study". Acta Neuropathol 106 (4): 374-82. PMID 12904992. 
  22. ^ White L et al. (2002). "Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants". Ann N Y Acad Sci 977 (9): 9-23. PMID 12480729. 
  23. ^ Ratnavalli E et al. (2002). "The prevalence of frontotemporal dementia". Neurology 58 (11): 1615-21. PMID 12058088. 
  24. ^ Galvin JE et al. (2006). "Clinical phenotype of Parkinson disease dementia". Neurology 67 (9): 1605-11. PMID 17101891. 
  25. ^ Gibbons D et al.. "Porphyria and dementia: a case report". Ir J Psych Med 20 (3): 96-99. http://www.ijpm.org/content/pdf/195/Dementia.pdf. 
  26. ^ Lamont P (2004). "Cognitive Decline in a Young Adult with Pre-Existent Developmental Delay – What the Adult Neurologist Needs to Know". Practical Neurology 4: 70-87. http://pn.bmj.com/cgi/content/abstract/4/2/70. 
  27. ^ Mukamal KJ, Kuller LH, Fitzpatrick AL, Longstreth WT, Mittleman MA, Siscovick DS (March 2003). "Prospective study of alcohol consumption and risk of dementia in older adults". JAMA 289 (11): 1405–13. doi:10.1001/jama.289.11.1405. PMID 12636463. 
  28. ^ Ganguli M, Vander Bilt J, Saxton JA, Shen C, Dodge HH (October 2005). "Alcohol consumption and cognitive function in late life: a longitudinal community study". Neurology 65 (8): 1210–7. doi:10.1212/01.wnl.0000180520.35181.24. PMID 16247047. 
  29. ^ Huang W, Qiu C, Winblad B, Fratiglioni L (October 2002). "Alcohol consumption and incidence of dementia in a community sample aged 75 years and older". J Clin Epidemiol 55 (10): 959–64. doi:10.1016/S0895-4356(02)00462-6. PMID 12464371. 
  30. ^ Sofi F, Cesari F, Abbate R, Gensini GF, Casini A (2008). "Adherence to Mediterranean diet and health status: meta-analysis". BMJ 337: a1344. doi:10.1136/bmj.a1344. PMID 18786971. 
  31. ^ Fillit H, Nash DT, Rundek T, Zuckerman A (June 2008). "Cardiovascular risk factors and dementia". Am J Geriatr Pharmacother 6 (2): 100–18. doi:10.1016/j.amjopharm.2008.06.004. PMID 18675769. 
  32. ^ Peters R, Beckett N, Forette F, et al (August 2008). "Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial". Lancet Neurol 7 (8): 683–9. doi:10.1016/S1474-4422(08)70143-1. PMID 18614402. 
  33. ^ Hu, Y; Russek (2008). "BDNF and the diseased nervous system: a delicate balance between adaptive and pathological processes of gene regulation.". Journal of neurochemistry 105 (1): 1–17. doi:10.1111/j.1471-4159.2008.05237.x. PMID 18208542. 
  34. ^ Schindowski, K; Belarbi; Buée (2008). "Neurotrophic factors in Alzheimer's disease: role of axonal transport.". Genes, brain, and behavior 7 Suppl 1: 43–56. doi:10.1111/j.1601-183X.2007.00378.x (inactive 2009-10-05). PMID 18184369. 
  35. ^ Tapia-Arancibia, L; Aliaga, E; Silhol, M; Arancibia, S (2008). "New insights into brain BDNF function in normal aging and Alzheimer disease.". Brain research reviews 59 (1): 201–20. doi:10.1016/j.brainresrev.2008.07.007. PMID 18708092. 
  36. ^ West Virginia Department of Health and Human Resources (with further links to experiments respectively)
  37. ^ Szekely, CA; Green; Breitner; Østbye; Beiser; Corrada; Dodge; Ganguli et al. (2008). "No advantage of A beta 42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies.". Neurology 70 (24): 2291–8. doi:10.1212/01.wnl.0000313933.17796.f6. PMID 18509093. 
  38. ^ Cornelius, C; Fastbom; Winblad; Viitanen (2004). "Aspirin, NSAIDs, risk of dementia, and influence of the apolipoprotein E epsilon 4 allele in an elderly population.". Neuroepidemiology 23 (3): 135–43. doi:10.1159/000075957. PMID 15084783. 
  39. ^ Etminan, M; Gill, S; Samii, A (2003). "Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies.". BMJ (Clinical research ed.) 327 (7407): 128. doi:10.1136/bmj.327.7407.128. PMID 12869452. 
  40. ^ Nilsson, SE; Johansson; Takkinen; Berg; Zarit; Mcclearn; Melander (2003). "Does aspirin protect against Alzheimer's dementia? A study in a Swedish population-based sample aged > or =80 years.". European journal of clinical pharmacology 59 (4): 313–9. doi:10.1007/s00228-003-0618-y. PMID 12827329. 
  41. ^ Anthony, JC; Breitner; Zandi; Meyer; Jurasova; Norton; Stone (2000). "Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists: the Cache County study.". Neurology 54 (11): 2066–71. PMID 10851364. 
  42. ^ Ad2000 Collaborative, Group; Bentham; Gray; Sellwood; Hills; Crome; Raftery (2008). "Aspirin in Alzheimer's disease (AD2000): a randomised open-label trial.". Lancet neurology 7 (1): 41–9. doi:10.1016/S1474-4422(07)70293-4. PMID 18068522. 
  43. ^ Akiyama, H; Barger; Barnum; Bradt; Bauer; Cole; Cooper; Eikelenboom et al. (2000). "Inflammation and Alzheimer's disease.". Neurobiology of aging 21 (3): 383–421. PMID 10858586. 
  44. ^ Tortosa, E; Avila; Pérez (2006). "Acetylsalicylic acid decreases tau phosphorylation at serine 422.". Neuroscience letters 396 (1): 77–80. doi:10.1016/j.neulet.2005.11.066. PMID 16386371. 
  45. ^ Hirohata, M; Ono; Naiki; Yamada (2005). "Non-steroidal anti-inflammatory drugs have anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro.". Neuropharmacology 49 (7): 1088–99. doi:10.1016/j.neuropharm.2005.07.004. PMID 16125740. 
  46. ^ Thomas, T; Nadackal; Thomas (2001). "Aspirin and non-steroidal anti-inflammatory drugs inhibit amyloid-beta aggregation.". Neuroreport 12 (15): 3263–7. PMID 11711868. 
  47. ^ "Bilingualism Has Protective Effect In Delaying Onset Of Dementia By Four Years, Canadian Study Shows". Medical News Today. 2007-01-11. http://www.medicalnewstoday.com/medicalnews.php?newsid=60646. Retrieved 2007-01-16. 
  48. ^ Aldridge, David, Music Therapy in Dementia Care, London : Jessica Kingsley Publishers, November 2000. ISBN 1853027766
  49. ^ Tuet, R.W.K.; Lam, L.C.W. (September 2006) "A preliminary study of the effects of music therapy on agitation in Chinese patients with dementia", Hong Kong Journal of Psychiatry, Volume 16, Number 3
  50. ^ Watanabe, Tomoyuki; et al., "Effects of music therapy for dementia: A systematic review", (in Japanese) Aichi University of Education Research Reports, v.55, pp. 57-61, March, 2005
  51. ^ Koger, Susan M.; Chapin Kathyn; Brotons, Melissa, "Is Music Therapy an Effective Intervention for Dementia? : A Meta-Analytic Review of Literature", Journal of Music Therapy 36(1), February 1999, pp.2-15.
  52. ^ Remington, Ruth, "Calming Music and Hand Massage With Agitated Elderly", Nursing Research 51(5): 317-323, September/October 2002.
  53. ^ Lleo A, Greenberg SM, Growdon JH. Current pharmacotherapy for Alzheimer's disease. Annu Rev Med. 2006;57:513-33. Review. PMID 16409164
  54. ^ Raina P, Santaguida P, Ismaila A, et al. (March 2008). "Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline". Annals of Internal Medicine 148 (5): 379–97. PMID 18316756. http://www.annals.org/cgi/content/full/148/5/379. Retrieved 2009-06-04. 
  55. ^ Atri A, Shaughnessy LW, Locascio JJ, Growdon JH (2008). "Long-term course and effectiveness of combination therapy in Alzheimer disease". Alzheimer Disease and Associated Disorders 22 (3): 209–21. doi:10.1097/WAD.0b013e31816653bc. PMID 18580597. 
  56. ^ Choi Y, Kim HS, Shin KY, et al. (November 2007). "Minocycline attenuates neuronal cell death and improves cognitive impairment in Alzheimer's disease models". Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology 32 (11): 2393–404. doi:10.1038/sj.npp.1301377. PMID 17406652. 
  57. ^ Thompson S, Herrmann N, Rapoport MJ, Lanctôt KL (April 2007). "Efficacy and safety of antidepressants for treatment of depression in Alzheimer's disease: a metaanalysis" (PDF). Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie 52 (4): 248–55. PMID 17500306. http://publications.cpa-apc.org/media.php?mid=586&xwm=true. Retrieved 2009-06-04. 
  58. ^ Bains J, Birks JS, Dening TR (2002). "The efficacy of antidepressants in the treatment of depression in dementia". Cochrane Database of Systematic Reviews (Online) (4): CD003944. doi:10.1002/14651858.CD003944. PMID 12519625. 
  59. ^ Lolk A, Gulmann NC (2006). "[Psychopharmacological treatment of behavioral and psychological symptoms in dementia]" (in Danish). Ugeskr Laeg 168 (40): 3429–32. PMID 17032610. 
  60. ^ Riederer P, Lachenmayer L (November 2003). "Selegiline's neuroprotective capacity revisited". Journal of Neural Transmission (Vienna, Austria : 1996) 110 (11): 1273–8. doi:10.1007/s00702-003-0083-x. PMID 14628191. 
  61. ^ "FDA MedWatch - 2008 Safety Alerts for Human Medical Products". FDA. http://www.fda.gov/medwatch/safety/2008/safety08.htm#Antipsychotics. 
  62. ^ http://www.guardian.co.uk/society/2009/nov/12/anti-psychotic-drugs-kill-dementia-patients

External links


Translations: Dementia
Top

Dansk (Danish)
n. - demens, sløvsind

Nederlands (Dutch)
dementie (ouderdomsziekte)

Français (French)
n. - démence

Deutsch (German)
n. - Schwachsinn, Wahnsinn

Ελληνική (Greek)
n. - (παθολ.) άνοια

Italiano (Italian)
demenza

Português (Portuguese)
n. - demência (f)

Русский (Russian)
слабоумие

Español (Spanish)
n. - demencia

Svenska (Swedish)
n. - dementi

中文(简体)(Chinese (Simplified))
痴呆

中文(繁體)(Chinese (Traditional))
n. - 癡呆

한국어 (Korean)
n. - 치매

日本語 (Japanese)
n. - 痴呆, 狂気

العربيه (Arabic)
‏(الاسم) اختلال عقلي شديد بسبب مرض في الدماغ او إصابه‏

עברית (Hebrew)
n. - ‮טירוף‬


 
 

Did you mean: dementia (in psychology), Dementia (film), Dementia (1999 Thriller Film)


 

Copyrights:

Medical Encyclopedia. © 2006 through a partnership of Answers Corporation. All rights reserved.  Read more
Dictionary. The American Heritage® Dictionary of the English Language, Fourth Edition Copyright © 2007, 2000 by Houghton Mifflin Company. Updated in 2009. Published by Houghton Mifflin Company. All rights reserved.  Read more
Britannica Concise Encyclopedia. Britannica Concise Encyclopedia. © 2006 Encyclopædia Britannica, Inc. All rights reserved.  Read more
Neurological Disorder. Gale Encyclopedia of Neurological Disorders. Copyright © 2005 by The Gale Group, Inc. All rights reserved.  Read more
World of the Body. The Oxford Companion to the Body. Copyright © 2001, 2003 by Oxford University Press. All rights reserved.  Read more
Thesaurus. Roget's II: The New Thesaurus, Third Edition by the Editors of the American Heritage® Dictionary Copyright © 1995 by Houghton Mifflin Company. Published by Houghton Mifflin Company. All rights reserved.  Read more
Answers Corporation Antonyms. © 1999-2009 by Answers Corporation. All rights reserved.  Read more
Dental Dictionary. Mosby's Dental Dictionary. Copyright © 2004 by Elsevier, Inc. All rights reserved.  Read more
Alternative Medicine Encyclopedia. Encyclopedia of Alternative Medicine. Copyright © 2005 by The Gale Group, Inc. All rights reserved.  Read more
Encyclopedia of Public Health. Encyclopedia of Public Health. Copyright © 2002 by The Gale Group, Inc. All rights reserved.  Read more
Columbia Encyclopedia. The Columbia Electronic Encyclopedia, Sixth Edition Copyright © 2003, Columbia University Press. Licensed from Columbia University Press. All rights reserved. www.cc.columbia.edu/cu/cup/ Read more
Psychoanalysis. International Dictionary of Psychoanalysis. Copyright © 2005 by The Gale Group, Inc. All rights reserved.  Read more
World of the Mind. The Oxford Companion to the Mind. Second Edition. Copyright © Oxford University Press, 2004. All rights reserved.  Read more
Veterinary Dictionary. Saunders Comprehensive Veterinary Dictionary 3rd Edition. Copyright © 2007 by D.C. Blood, V.P. Studdert and C.C. Gay, Elsevier. All rights reserved.  Read more
Answers Corporation Blogs. © 1999-2009 by Answers Corporation. All rights reserved.  Read more
Wikipedia. This article is licensed under the Creative Commons Attribution/Share-Alike License. It uses material from the Wikipedia article "Dementia" Read more
Translations. Copyright © 2007, WizCom Technologies Ltd. All rights reserved.  Read more